Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 10:49 PM
Study NCT ID:
NCT06394167
Status:
COMPLETED
Last Update Posted:
2025-03-20
First Post:
2024-04-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-09
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-18
Completion Date Type:
ACTUAL
First Submit Date:
2024-04-26
First Submit QC Date:
None
Study First Post Date:
2024-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-19
Last Update Post Date:
2025-03-20
Last Update Post Date Type:
ACTUAL